Arzu Onar‐Thomas

10.6k total citations
130 papers, 3.3k citations indexed

About

Arzu Onar‐Thomas is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Arzu Onar‐Thomas has authored 130 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Genetics, 42 papers in Neurology and 36 papers in Molecular Biology. Recurrent topics in Arzu Onar‐Thomas's work include Glioma Diagnosis and Treatment (86 papers), Neuroblastoma Research and Treatments (38 papers) and Brain Metastases and Treatment (15 papers). Arzu Onar‐Thomas is often cited by papers focused on Glioma Diagnosis and Treatment (86 papers), Neuroblastoma Research and Treatments (38 papers) and Brain Metastases and Treatment (15 papers). Arzu Onar‐Thomas collaborates with scholars based in United States, Canada and Australia. Arzu Onar‐Thomas's co-authors include Amar Gajjar, Maryam Fouladi, Alberto Broniscer, Richard J. Gilbertson, Clinton F. Stewart, James M. Boyett, Larry E. Kun, Roger J. Packer, Jie Huang and Tina Young Poussaint and has published in prestigious journals such as Cell, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Arzu Onar‐Thomas

124 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arzu Onar‐Thomas United States 33 1.8k 1.2k 966 631 615 130 3.3k
Susan Chi United States 35 1.6k 0.9× 1.6k 1.3× 1.1k 1.2× 562 0.9× 443 0.7× 121 3.6k
Irene Slavc Austria 32 1.3k 0.7× 1.3k 1.1× 876 0.9× 575 0.9× 474 0.8× 131 3.2k
Maria Luisa Garrè Italy 33 2.0k 1.1× 1.2k 0.9× 957 1.0× 582 0.9× 495 0.8× 136 3.7k
Regina I. Jakacki United States 35 2.3k 1.3× 969 0.8× 1.8k 1.8× 756 1.2× 679 1.1× 94 4.0k
Dana Wallace United States 27 1.4k 0.8× 999 0.8× 856 0.9× 524 0.8× 364 0.6× 40 2.8k
Tianni Zhou United States 26 1.8k 1.0× 835 0.7× 983 1.0× 567 0.9× 222 0.4× 34 2.4k
Herbert B. Newton United States 29 1.2k 0.7× 1.2k 1.0× 522 0.5× 632 1.0× 574 0.9× 86 3.0k
Stewart J. Kellie Australia 30 1.9k 1.1× 1.2k 1.0× 1.0k 1.0× 871 1.4× 471 0.8× 76 3.5k
Valérie Rigau France 36 1.4k 0.8× 893 0.7× 531 0.5× 654 1.0× 479 0.8× 123 3.6k
Robert Hammond Canada 25 1.6k 0.9× 970 0.8× 874 0.9× 728 1.2× 195 0.3× 111 3.5k

Countries citing papers authored by Arzu Onar‐Thomas

Since Specialization
Citations

This map shows the geographic impact of Arzu Onar‐Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arzu Onar‐Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arzu Onar‐Thomas more than expected).

Fields of papers citing papers by Arzu Onar‐Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arzu Onar‐Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arzu Onar‐Thomas. The network helps show where Arzu Onar‐Thomas may publish in the future.

Co-authorship network of co-authors of Arzu Onar‐Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Arzu Onar‐Thomas. A scholar is included among the top collaborators of Arzu Onar‐Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arzu Onar‐Thomas. Arzu Onar‐Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fangusaro, Jason, Arzu Onar‐Thomas, Tina Young Poussaint, et al.. (2025). A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4. Neuro-Oncology. 27(9). 2415–2428. 2 indexed citations
2.
Onar‐Thomas, Arzu, et al.. (2024). Computing Power and Sample Size for the False Discovery Rate in Multiple Applications. Genes. 15(3). 344–344. 6 indexed citations
3.
4.
Monje, Michelle, Tabitha Cooney, John Glod, et al.. (2023). Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047). Neuro-Oncology. 25(12). 2262–2272. 31 indexed citations
5.
Pribnow, Allison, Barbara Jonchère, Jingjing Liu, et al.. (2022). Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma. Molecular Cancer Therapeutics. 21(8). 1306–1317. 5 indexed citations
6.
Murphy, Erin S., Girish Dhall, Jason Fangusaro, et al.. (2022). A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors. International Journal of Radiation Oncology*Biology*Physics. 113(1). 143–151. 10 indexed citations
7.
Khan, Raja B., Zoltán Patay, Paul Klimo, et al.. (2021). Clinical features, neurologic recovery, and risk factors of postoperative posterior fossa syndrome and delayed recovery: a prospective study. Neuro-Oncology. 23(9). 1586–1596. 47 indexed citations
8.
Fuller, Christine, Olivia Campagne, Tong Lin, et al.. (2021). A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study. Clinical Cancer Research. 27(9). 2442–2451. 17 indexed citations
9.
Bartels, Ute, Arzu Onar‐Thomas, Sunita K. Patel, et al.. (2021). Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children’s Oncology Group study. Neuro-Oncology. 24(6). 974–983. 32 indexed citations
10.
Leary, Sarah, Lindsay Kilburn, J. Russell Geyer, et al.. (2021). Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026). Neuro-Oncology. 24(7). 1178–1190. 21 indexed citations
11.
Zhu, Liang, Yimei Li, Yongqiang Tang, et al.. (2021). Sample size calculation for recurrent event data with additive rates models. Pharmaceutical Statistics. 21(1). 89–102. 1 indexed citations
12.
Campagne, Olivia, Tong Lin, Jie Huang, et al.. (2019). Exposure–Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for Dosing. Clinical Cancer Research. 26(7). 1563–1573. 19 indexed citations
13.
Nimmervoll, Birgit, Nidal Boulos, Jason Dapper, et al.. (2018). Establishing a Preclinical Multidisciplinary Board for Brain Tumors. Clinical Cancer Research. 24(7). 1654–1666. 9 indexed citations
14.
Zukotynski, Katherine, Sridhar Vajapeyam, Frederic H. Fahey, et al.. (2017). Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium. Journal of Nuclear Medicine. 58(8). 1264–1269. 29 indexed citations
15.
Xu, Heng, Giles Robinson, Jie Huang, et al.. (2015). Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss. Nature Genetics. 47(3). 263–266. 92 indexed citations
16.
Hoffman, Lindsey M., Maryam Fouladi, James M. Olson, et al.. (2015). Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study. Child s Nervous System. 31(8). 1283–1289. 41 indexed citations
17.
Paugh, Barbara S., Xiaoyan Zhu, Chunxu Qu, et al.. (2013). Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas. Cancer Research. 73(20). 6219–6229. 150 indexed citations
18.
Broniscer, Alberto, Sharyn D. Baker, Cynthia Wetmore, et al.. (2013). Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma. Clinical Cancer Research. 19(11). 3050–3058. 74 indexed citations
19.
Paugh, Barbara S., Alberto Broniscer, Chunxu Qu, et al.. (2011). Genome-Wide Analyses Identify Recurrent Amplifications of Receptor Tyrosine Kinases and Cell-Cycle Regulatory Genes in Diffuse Intrinsic Pontine Glioma. Journal of Clinical Oncology. 29(30). 3999–4006. 219 indexed citations
20.
Fouladi, Maryam, Clinton F. Stewart, Susan M. Blaney, et al.. (2010). Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study. Journal of Clinical Oncology. 28(27). 4221–4227. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Chi Breakdown of academic impact, for papers by Irene Slavc Breakdown of academic impact, for papers by Maria Luisa Garrè Breakdown of academic impact, for papers by Regina I. Jakacki Breakdown of academic impact, for papers by Dana Wallace Breakdown of academic impact, for papers by Tianni Zhou Breakdown of academic impact, for papers by Herbert B. Newton Breakdown of academic impact, for papers by Stewart J. Kellie Breakdown of academic impact, for papers by Valérie Rigau Breakdown of academic impact, for papers by Robert Hammond
Rankless by CCL
2026